Breaking News
February 18, 2019 - Heavy smoking could lead to vision loss, study finds
February 18, 2019 - New diagnostic test for malaria uses spit, not blood
February 18, 2019 - New therapeutic molecules show promise in reversing memory loss related to depression, aging
February 18, 2019 - Darla Shine joins anti-vaccination campaigners
February 18, 2019 - New study outlines sex-specific issues in ischemic heart disease
February 18, 2019 - Drug combinations could become first-line treatment for metastatic kidney cancer
February 18, 2019 - Lifetime adversity, increased neural processing during trauma combine to intensify core PTSD symptoms
February 18, 2019 - HRQoL Scores Decrease With Treatment Line in Multiple Myeloma
February 18, 2019 - Convincing evidence that type 2 diabetes is a cause of erectile dysfunction
February 18, 2019 - Art Institute of Chicago announces results of research on five terracotta sculptures
February 18, 2019 - New PET/CT tracer shows high detection rate for diagnosis of acute venous thromboembolism
February 18, 2019 - Smoking may blight immune response against melanoma and reduce survival
February 18, 2019 - How Inactivity and Junk Food Can Harm Your Brain
February 18, 2019 - Diabetes tops common conditions for frequent geriatric emergency patients
February 18, 2019 - Longer-lived sperm produces offspring with healthier lifespans
February 18, 2019 - New dental adhesive prevents tooth decay around orthodontic brackets
February 18, 2019 - New eHealth tool shows potential to improve quality of asthma care
February 18, 2019 - New Australian initiative helps emergency clinicians to improve patient care
February 17, 2019 - Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from the FDA for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
February 17, 2019 - Researchers identify faulty ‘brake’ that interferes with heart muscle’s ability to contract and relax
February 17, 2019 - Support from trusted adults can reduce risk of dying in suicidal teens, finds study
February 17, 2019 - Heart attack awareness improved since 2008
February 17, 2019 - Exercise gives a better brain boost to older men than women
February 17, 2019 - New research disproves previous assumptions of how looks influence personality
February 17, 2019 - Cannabis use as a teenager linked to depression later in life
February 17, 2019 - Sinks by Toilets in ICU Patient Rooms Harbor Harmful Bacteria
February 17, 2019 - Cancer cells’ plasticity makes them harder to stop
February 17, 2019 - Young cannabis users have increased risk of depression and suicidal behavior
February 17, 2019 - Tasmanian Devils Likely to Survive Cancer Scourge
February 17, 2019 - Neoadjuvant PD-1 blockade seems effective in glioblastoma
February 17, 2019 - Personal, social factors play role in enabling sustainable return to work after ill health
February 17, 2019 - Mouse studies show ‘inhibition’ theory of autism wrong
February 17, 2019 - Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins
February 17, 2019 - Use of liver grafts from older donors decreased despite better outcomes in recipients
February 17, 2019 - MUSC researchers discover new mechanism for a class of anti-cancer drugs
February 17, 2019 - HPV misconceptions are causing women to miss smear tests
February 17, 2019 - Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price
February 17, 2019 - Researchers say auditory testing can identify children for autism screening
February 17, 2019 - New method analyzes how single biological cells react to stressful situations
February 17, 2019 - WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers
February 17, 2019 - ADHD diagnoses poorly documented
February 17, 2019 - Majority of gender minority youth do not identify with traditional sexual identity labels
February 17, 2019 - AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma
February 17, 2019 - Lower Birth Weight May Up Risk for Psychiatric Disorders
February 17, 2019 - Scientists identify reversible molecular defect underlying rheumatoid arthritis
February 17, 2019 - Moffitt researchers shed light on how CAR T cells function mechanistically
February 16, 2019 - Female Anatomy May Play Big Role in Sperm’s Success
February 16, 2019 - BMI may mediate inverse link between fiber intake, knee OA
February 16, 2019 - Movement impairments in autism can be reversed through behavioral training
February 16, 2019 - Studies address racial disparities in postpartum period and cardiovascular health
February 16, 2019 - Scientists implicate hidden genes in the severity of autism symptoms
February 16, 2019 - Decreased deep sleep linked to early signs of Alzheimer’s disease
February 16, 2019 - Neuroscientists show how the brain responds to texture
February 16, 2019 - Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
February 16, 2019 - What Can I Do About Sweating? (for Teens)
February 16, 2019 - Companies navigate dementia conversations with older workers
February 16, 2019 - Newly developed stem cell technologies show promise for treating PD patients
February 16, 2019 - Collaborative material research could advance self-assembling nanomaterials
February 16, 2019 - Researchers take major step in creating technology that mimics the human brain
February 16, 2019 - Erasing memories associated with cocaine use reduces drug seeking behavior
February 16, 2019 - Artificial intelligence can accurately predict prognosis of ovarian cancer patients
February 16, 2019 - Racial disparities in cancer deaths on the decline for America
February 16, 2019 - FDA authorizes new interoperable insulin pump for children, adults with diabetes
February 16, 2019 - Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link
February 16, 2019 - Skin Cancer Screening: MedlinePlus Lab Test Information
February 16, 2019 - ‘Happiness’ exercises can boost mood in those recovering from substance use disorder
February 16, 2019 - Cell manipulation could soon halt or reverse aging
February 16, 2019 - Pumped Breast Milk Falls Short of Breastfed Version
February 16, 2019 - Men’s porn habits could fuel partners’ eating disorders, study suggests
February 16, 2019 - Rapid progression of age-related diseases may result from formation of vicious cycles
February 16, 2019 - Immune checkpoint molecule protects against future development of cancer
February 16, 2019 - New method produces hydrogels that have properties similar to cells’ environment
February 16, 2019 - $4.1 million funding for heart research on Valentine’s Day
February 16, 2019 - General anesthesia in early infancy unlikely to have lasting effects on developing brains
February 16, 2019 - New breakthroughs for muscular dystrophy research
February 16, 2019 - First Opinion: Embryo editing for higher IQ is a fantasy. Embryo profiling for it is almost here
February 16, 2019 - Vapers develop cancer-related gene deregulation as cigarette smokers
February 16, 2019 - Bringing Antimicrobial Susceptibility Testing (AST) to the Community
February 16, 2019 - Decolonization protocol after hospital discharge can prevent dangerous infections
February 16, 2019 - Children with ASD more likely to face maltreatment, study finds

The London Clinic exhibits innovative technology to treat Parkinson’s disease at Arab Health

image_pdfDownload PDFimage_print

A pioneering technology that allows patients to control their Parkinson’s disease symptoms using an iPod will be showcased at Arab Health by a renowned UK hospital.

The London Clinic, a private hospital and charity in the heart of the Harley Street Medical Area, will attend the exhibition to highlight one of their latest techniques – Deep Brain Stimulation (DBS).

DBS is a surgical procedure that involves implanting electrodes into the areas of the brain that control movement. These electrodes are then connected to a pulse generator via fine wires that is placed under the skin in the upper chest or stomach area. When the pulse generator (a device like a pacemaker), is turned on, it delivers precise electrical signals to the targeted area to modulate or disrupt abnormal signals that cause the motor symptoms of Parkinson’s disease.

Parkinson’s disease is a chronic progressive neurological disease that affects an estimated 6.9 million people worldwide, a figure expected to grow to 14.2 million by 2040. The main symptoms of Parkinson’s disease are tremor, slow movement and stiffness. Many of the symptoms are caused by the loss of nerve cells in the brain that produce a chemical messenger called dopamine.

There is currently no cure for Parkinson’s, but drugs that increase or substitute for dopamine can help manage the symptoms in the early stages of the disease. However, as the condition progresses, medication can be less effective at reliably controlling symptoms, making it increasingly difficult for people with Parkinson’s disease to live healthy and independent lives. Evidence from clinical trials suggests that Deep Brain Stimulation (DBS) should be considered soon after patients start to experience fluctuations in the control of symptoms with medication alone.

Mr Erlick Pereira, Consultant Neurosurgeon, explains:

The London Clinic is the first private hospital in the UK to use the innovative Abbott InfinityTM DBS System to treat Parkinson’s disease patients. The electrodes implanted into the brain are segmented, which enables us to precisely steer electrical currents to the desired area in the brain, maximizing the therapeutic benefit whilst reducing the potential side effects. We perform DBS with a minimally invasive technique, without shaving the hair and under general anesthetic for patient comfort.

The Abbott Medical InfinityTM DBS system uses Bluetooth and iOS software, meaning the levels of stimulation from DBS can be adjusted with an external programmer to meet the patient’s specific needs. Patients are given an easy-to-use iPod controller that they can use to adjust their DBS settings within a pre-set range (set by their consultant), giving them greater control over their Parkinson’s disease symptoms. An added benefit of using a system on iOS is that it can be easily upgraded as the latest therapy advancements are approved, and is available in multiple languages.

Patients with certain types of chronic pain and other movement disorders such as dystonia, essential tremor and epilepsy can also benefit from DBS when their medication is ineffective or results in intolerable side effects.

Dr Binith Cheeran, Consultant Neurologist, says:

Patients are carefully selected for DBS by multidisciplinary teams. Clinical nurse specialists and specialist physiotherapists also play a key role in the treatment and recovery of the patient.

“As the symptoms of Parkinson’s disease become harder to manage, patients are looking for ways to take back control over their lives. DBS can significantly improve a patient’s quality of life and help them reduce their medication,” adds Dr Cheeran.

DBS is one form of neuromodulation, the alteration of nerve activity by electrical or pharmaceutical agents. The London Clinic also offers spinal cord stimulation to treat patients with chronic pain and dorsal root ganglion therapy for localized chronic pain. The London Clinic will be on stand to discuss the neuromodulation services and other pioneering therapies for a wide range of conditions at Arab Health 2018.

The Harley Street Medical Area is a collective of hospitals, clinics and specialists who deliver outstanding patient care through pioneering treatments and cutting-edge technologies. The Harley Street Medical Area Stand is a regular attender of Arab Health and will be located in the UK Pavilion on stand H7E30 – The London Clinic can be found within this stand.

The Arab Health Exhibition & Congress, the largest healthcare exhibition in the Middle East, is taking place from 29th January to the 1st February 2018, at the Dubai Convention and Exhibition Centre.

Source:

http://www.thelondonclinic.co.uk/

Tagged with:

About author

Related Articles